Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samantha Littler

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Open Biology|August 29, 2019
Oncogenic MYC amplifies mitotic perturbationsSamantha Littler, Olivia Sloss, Bethany Geary, et al.
Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology|August 17, 2023
Exploiting a living biobank to delineate mechanisms underlying disease-specific chromosome instabilityLouisa Nelson, Bethany M Barnes, Anthony Tighe, et al.
Cell Reports. Medicine|June 4, 2025
Screening a living biobank identifies cabazitaxel as a strategy to combat acquired taxol resistance in high-grade serous ovarian cancerAnthony Tighe, Louisa Nelson, Robert D Morgan, et al.
Iscience|June 9, 2025
Targeting SUMOylation in ovarian cancer: Sensitivity, resistance, and the role of MYCSamantha Littler, Bethany M Barnes, Rhys Owen, et al.
Cancer Cell|July 16, 2015
MYC Is a Major Determinant of Mitotic Cell FateCaroline Topham, Anthony Tighe, Peter Ly, et al.
Cell Reports|October 18, 2018
The p38α Stress Kinase Suppresses Aneuploidy Tolerance by Inhibiting Hif-1αSusana Simões-Sousa, Samantha Littler, Sarah L Thompson, et al.
NAR Cancer|July 17, 2024
Intrinsic PARG inhibitor sensitivity is mimicked by <i>TIMELESS</i> haploinsufficiency and rescued by nucleoside supplementationCamilla Coulson-Gilmer, Samantha Littler, Bethany M Barnes, et al.
Cancer Cell|March 20, 2019
DNA Replication Vulnerabilities Render Ovarian Cancer Cells Sensitive to Poly(ADP-Ribose) Glycohydrolase InhibitorsNisha Pillay, Anthony Tighe, Louisa Nelson, et al.
Nature Communications|February 15, 2020
A living biobank of ovarian cancer ex vivo models reveals profound mitotic heterogeneityLouisa Nelson, Anthony Tighe, Anya Golder, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Open Biology|August 29, 2019
Oncogenic MYC amplifies mitotic perturbationsSamantha Littler, Olivia Sloss, Bethany Geary, et al.
Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology|August 17, 2023
Exploiting a living biobank to delineate mechanisms underlying disease-specific chromosome instabilityLouisa Nelson, Bethany M Barnes, Anthony Tighe, et al.
Cell Reports. Medicine|June 4, 2025
Screening a living biobank identifies cabazitaxel as a strategy to combat acquired taxol resistance in high-grade serous ovarian cancerAnthony Tighe, Louisa Nelson, Robert D Morgan, et al.
Iscience|June 9, 2025
Targeting SUMOylation in ovarian cancer: Sensitivity, resistance, and the role of MYCSamantha Littler, Bethany M Barnes, Rhys Owen, et al.
Cancer Cell|July 16, 2015
MYC Is a Major Determinant of Mitotic Cell FateCaroline Topham, Anthony Tighe, Peter Ly, et al.
Cell Reports|October 18, 2018
The p38α Stress Kinase Suppresses Aneuploidy Tolerance by Inhibiting Hif-1αSusana Simões-Sousa, Samantha Littler, Sarah L Thompson, et al.
NAR Cancer|July 17, 2024
Intrinsic PARG inhibitor sensitivity is mimicked by <i>TIMELESS</i> haploinsufficiency and rescued by nucleoside supplementationCamilla Coulson-Gilmer, Samantha Littler, Bethany M Barnes, et al.
Cancer Cell|March 20, 2019
DNA Replication Vulnerabilities Render Ovarian Cancer Cells Sensitive to Poly(ADP-Ribose) Glycohydrolase InhibitorsNisha Pillay, Anthony Tighe, Louisa Nelson, et al.
Nature Communications|February 15, 2020
A living biobank of ovarian cancer ex vivo models reveals profound mitotic heterogeneityLouisa Nelson, Anthony Tighe, Anya Golder, et al.
Pageof 1